The process begins with extracting dendritic cells from the patient’s blood. These cells are then cultured in the laboratory and exposed to antigens specific to the patient’s cancer. Once the dendritic cells have been "educated" to recognize the cancer antigens, they are reintroduced into the patient’s body. The goal is for these treated dendritic cells to activate T-cells and direct them to target and destroy cancer cells.
